Gala vs GoodRx Care: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Gala beats GoodRx Care overall, scoring 7.2/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $149/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke.

A side-by-side comparison of Gala and GoodRx Care covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Gala

#40 of 49

7.2/10

Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

GoodRx Care

#49 of 49

6.2/10

GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.

Visit GoodRx Care

Feature	Gala	GoodRx Care
Our Score	7.2/10	6.2/10
Starting Price	$149/mo	$119/mo
Medication Type	Both	Brand
Insurance Accepted	No	Yes
Best For	Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging	Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill
Ranking	#40	#49

Pros & Cons Compared

Gala

Pros

+Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
−Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
−Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

GoodRx Care

Pros

+2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
+Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
+Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
+Insurance accepted — GoodRx's integration with savings cards can stack with coverage

Cons

−Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
−Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
−Subscription model means ongoing monthly fee even in maintenance months
−Follow-up clinical care is still basic compared to dedicated GLP-1 platforms

Our Verdict

Gala edges out GoodRx Care with a score of 7.2/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Gala's $149/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Gala nor GoodRx Care feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review